Home/Filings/4/0000950170-25-048551
4//SEC Filing

Kropotova Alexandra 4

Accession 0000950170-25-048551

CIK 0001833214other

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:19 PM ET

Size

5.2 KB

Accession

0000950170-25-048551

Insider Transaction Report

Form 4
Period: 2025-03-27
Kropotova Alexandra
CHIEF MEDICAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2025-03-271,17947,249 total
Footnotes (3)
  • [F1]Represents shares of the Issuer's common stock ("Common Stock") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units ("RSUs").
  • [F2]Includes 24,128 shares of Common Stock and 23,121 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
  • [F3]Each RSU represents a contingent right to receive one share of Common Stock.

Documents

1 file

Issuer

SAB Biotherapeutics, Inc.

CIK 0001833214

Entity typeother

Related Parties

1
  • filerCIK 0001825323

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:19 PM ET
Size
5.2 KB